AusPAR: Interferon beta-1a

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

4 December 2013
AusPAR Details
AusPAR
AusPAR: Interferon beta-1a (pdf, 592 KB)
AusPAR: Interferon beta-1a (docx, 2 MB)
Attachment: Product Information: Interferon beta-1a (pdf, 307 KB)
Attachment: Product Information: Interferon beta-1a (docx, 448 KB)
Attachment: Extract from Clinical Evaluation Report: Interferon beta-1a (pdf, 1 MB)
AusPAttachment: Extract from Clinical Evaluation Report: Interferon beta-1aAR Attachment 2: Extract from the Clinical Evaluation Report for interferon beta-1a (docx, 7 MB)
Active Ingredient
Interferon beta-1a
Product Name
Rebif
Sponsor
Merck Serono Australia Pty Ltd
Submission Number
PM-2012-00320-3-1
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
10 October 2013
Publication Date

4 December 2013
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/831